This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3oof
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 3oof is ON HOLD Authors: Rudolph, M.G. Description: Lead optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists f...) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 3oof is ON HOLD | + | The entry 3oof is ON HOLD until Paper Publication |
Authors: Rudolph, M.G. | Authors: Rudolph, M.G. | ||
| - | Description: | + | Description: Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep 22 14:33:56 2010'' |
Revision as of 11:24, 22 September 2010
Unreleased structure
The entry 3oof is ON HOLD until Paper Publication
Authors: Rudolph, M.G.
Description: Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid
Page seeded by OCA on Wed Sep 22 14:33:56 2010
